Skip to main content
. 2024 Mar 18;12(1):8. doi: 10.3390/proteomes12010008

Figure 1.

Figure 1

Classification of ovarian carcinomas (A) and therapeutic approaches commonly used in the clinics (B). PARP, poly(ADP-ribose) polymerase; NTRK, neurotrophic receptor tyrosine kinase; GnRH, gonadotropin-releasing hormone.